A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population

Clinical trial NCT00965822 · COMPLETED

Trial details

NCT number

NCT00965822

Sponsor

Afexa Life Sciences Inc

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-09-01

Primary completion

2012-04-01

Enrollment

293

View on ClinicalTrials.gov